IceCure Medical
ICCM
14 hedge funds and large institutions have $268K invested in IceCure Medical in 2024 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
123% more capital invested
Capital invested by funds: $120K → $268K (+$147K)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
17% more funds holding
Funds holding: 12 → 14 (+2)
0.02% more ownership
Funds ownership: 0.01% → 0.03% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$180K |
| 2 |
Renaissance Technologies
New York
|
+$70.5K |
| 3 |
VF
Virtu Financial
New York
|
+$28.8K |
| 4 |
Two Sigma Investments
New York
|
+$22.6K |
| 5 |
CIA
Concurrent Investment Advisors
Tampa,
Florida
|
+$10.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
-$22K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$18.3K |
| 3 |
MG
Mather Group
Chicago,
Illinois
|
-$1.71K |
ICCM Hedge Fund Activity: Q2 2024 in Review
14 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q2 2024, worth a combined $268K — up 123% from $120K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ICCM positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $180K. The largest seller was HRT Financial, exiting entirely with an estimated $22K sold.
- 14 institutional investors held IceCure Medical (ICCM) as of Q2 2024, up from 12 in Q1 2024.
- Funds reported $268K of IceCure Medical stock for Q2 2024, up 123% quarter-over-quarter.
- 5 funds opened new IceCure Medical positions in Q2 2024 and 3 closed out, a net change of +2 holders.
- The largest IceCure Medical buyer in Q2 2024 was Citadel Advisors, an estimated $180K added.
- The largest IceCure Medical seller in Q2 2024 was HRT Financial, an estimated $22K sold.
Based on aggregated 13F filings for Q2 2024.